Profile: Utak Laboratories, Inc. deals with adulteration controls, oral fluid controls, serum controls, urine controls and whole blood controls. Our whole blood drugs of abuse contain benzoylecgonine, cocaine, cocaethylene, d-amphetamine, d-methamphetamine, morphine, codeine and hydrocodone. Our homocysteine controls are available in four concentration levels. This sulfur containing amino acid is a risk factor in cardiovascular disease. The whole blood lead controls are offered in four separate blood lead decision levels classified into background, mild toxicity and moderate toxicity elevated ranges.
The company has revenues of < USD 1 Million.
FDA Registration Number: 2022375
6 Products/Services (Click for related suppliers)
|
• Drug Mixture Control Materials (FDA Code: DIF / 862.3280) A clinical toxicology control material is a device intended to provide an estimation of the precision of a device test system and to detect and monitor systematic deviations from accuracy resulting from reagent or instrument defects. This generic type of device includes various single, and multi-analyte control materials. |
• Drug Specific Control Test (FDA Code: LAS / 862.3280) |
• Drugs of Abuse Test Systems (FDA Code: MGX) |
• Fluid Control Solidifier |
• Multi Analyte Control (FDA Code: JJY / 862.1660) A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls. |
• Urine Dipstick Control |